-+ 0.00%
-+ 0.00%
-+ 0.00%

CVS Health Raises FY2026 Adj EPS Guidance from $7.30-$7.50 to $7.90-$8.10 vs $7.45 Est; FY2026 Revenue expected to be more than $414.000M vs $409.235B Est

Benzinga·08/05/2026 10:32:40
Listen to the news
CVS Health (NYSE:CVS) raises FY2026 Adj EPS guidance from $7.30-$7.50 to $7.90-$8.10 vs $7.45 analyst estimate. FY2026 Revenue expected to be more than $414.000M vs $409.235B Est